These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 9603632)

  • 1. Immunopharmacology of oral betalactams.
    Periti P
    J Chemother; 1998 Apr; 10(2):91-6. PubMed ID: 9603632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunopharmacology of antibiotics: direct and indirect immunomodulation of defence mechanisms.
    Hamilton-Miller JM
    J Chemother; 2001 Apr; 13(2):107-11. PubMed ID: 11330355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Desirable and undesirable immunotropic effects of antibiotics: immunomodulating properties of cefaclor.
    Dabrowski MP; Stankiewicz W
    J Chemother; 2001 Dec; 13(6):615-20. PubMed ID: 11806622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative in vitro activity of cefixime, cefaclor and loracarbef against urinary pathogens.
    Hamilton-Miller JM; Brumfitt W
    Drugs Exp Clin Res; 1991; 17(10-11):517-9. PubMed ID: 1841042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro effect on group A streptococci of loracarbef versus cefadroxil, cefaclor and penicillin V.
    Kamme C; Petersson AC
    Scand J Infect Dis; 1993; 25(1):37-42. PubMed ID: 8460347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro evaluation of Ly 163892, a new oral cephalosporin.
    Schäfer V; Knothe H; Sammann A; Heidron F
    J Chemother; 1989 Jul; 1(4 Suppl):123-4. PubMed ID: 16312333
    [No Abstract]   [Full Text] [Related]  

  • 7. [Determination of the bactericidal potency of cefatrizine and other oral antibiotics against Haemophilus influenzae, Klebsiella pneumoniae and Streptococcus pyogenes].
    Carlone NA; Cuffini AM; Tullio V; Barone R
    G Batteriol Virol Immunol; 1986; 79(7-12):264-71. PubMed ID: 3331159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibiotics and neutrophil function--potential immunomodulating activities.
    Gemmell CG
    J Antimicrob Chemother; 1993 Feb; 31 Suppl B():23-33. PubMed ID: 8449843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cefaclor: a contemporary look at susceptibility of key pathogens from around the globe.
    Preston DA; Turik M
    J Chemother; 1998 Jun; 10(3):195-202. PubMed ID: 9669643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Growth curves and killing rate of Haemophilus influenzae exposed to amoxicillin, cefaclor and cefotaxime].
    Yourassowsky E; Van der Linden MP; Lismont MJ; Crokaert F; Glupczynski Y
    Pathol Biol (Paris); 1986 May; 34(5):381-4. PubMed ID: 3534710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of cefaclor, cefetamet and Ro 40-6890 on inflammatory responses of human granulocytes.
    Scheffer J; Knöller J; Cullmann W; König W
    J Antimicrob Chemother; 1992 Jul; 30(1):57-66. PubMed ID: 1429337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparative antibacterial activity of cefpodoxime, cefuroxime and cefaclor against strict anaerobic bacteria].
    Dubreuil L; Derriennic M; Sedallian A
    Pathol Biol (Paris); 1990 May; 38(5):343-6. PubMed ID: 2367150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparison of the activity of cefaclor with amoxicillin, erythromycin and doxycycline in an in vitro model].
    Wiedemann B
    Arzneimittelforschung; 1983; 33(9):1232-5. PubMed ID: 6357205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activity of cefdinir against respiratory pathogens isolated in Sicily with reference to beta-lactamase production.
    Blandino G; Aleo G; Caccamo F; Nicolosi VM; Siracusa V; Speciale A
    J Chemother; 1996 Jun; 8(3):193-9. PubMed ID: 8808715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of antimicrobial activity of Cefaclor on common respiratory tract pathogens in Pakistan.
    Ahmed A; Hafiz S; Rafiq M; Tariq N; Abdulla EM; Hussain S; Azim R; Siddiqui SJ; Awan A; Khan KZ; Fareed A
    J Pak Med Assoc; 2002 Jan; 52(1):7-11. PubMed ID: 11963587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [In vitro activity of fluoroquinolones and oral beta lactam antibiotics against clinical isolates of Escherichia coli].
    Gómez-Martínez J; Marco F; Mensa J; Espasa M; Martínez JA; Jiménez de Anta MT
    Rev Esp Quimioter; 1999 Mar; 12(1):54-7. PubMed ID: 10209063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro activity of oral cephalosporins against pediatric isolates of Streptococcus pneumoniae non-susceptible to penicillin, amoxicillin or erythromycin.
    Fenoll A; Giménez MJ; Robledo O; Aguilar L; Tarragó D; Granizo JJ; Gimeno M; Coronel P
    J Chemother; 2008 Apr; 20(2):175-9. PubMed ID: 18467242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reassessment of the cefaclor breakpoint for Streptococcus pneumoniae.
    MacKenzie FM; Milne KE; Gould IM
    Int J Antimicrob Agents; 2004 Apr; 23(4):337-42. PubMed ID: 15081081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunomodulatory properties of cefaclor: in vivo effect on cytokine release and lymphoproliferative response in rats.
    Mangano K; Quattrocchi C; Aiello C; Scalia G; Speciale A; Nicoletti G; Di Marco R
    J Chemother; 2006 Dec; 18(6):641-7. PubMed ID: 17267343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro comparison of Staphylococcus pseudintermedius susceptibility to common cephalosporins used in dogs.
    Westermeyer RR; Roy AF; Mitchell MS; Merchant SR
    Vet Ther; 2010; 11(3):E1-9. PubMed ID: 20960413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.